Literature DB >> 23184125

Local resistance patterns to antimicrobials in internal medicine: a focused report from the REGIMEN (REGistro Infezioni in MEdicina INterna) study.

Marco Cei1, Riccardo Pardelli, Spartaco Sani, Nicola Mumoli.   

Abstract

The treatment for infections in hospitalized patients can be summarized in the timely start of empirical therapy, followed by adjustment on the basis of isolates and microbial susceptibilities. Initial therapy may be based on international guidelines. However, to know local frequencies of bacterial and fungal strains together with patterns of drug resistance should be a better approach to therapy. REGIMEN is a retrospective observational study of all consecutive recorded bacterial and fungal isolates, collected between October 2009 and August 2011 from patients admitted in a 53-bedded ward of internal medicine of a non-teaching Italian hospital. We investigated type of samples and of microorganisms, patterns of susceptibility and resistance to antibiotics, and in-hospital mortality. A total of 504 samples were examined (244 from urine, 189 from blood and 71 from skin and various exudates). Participants were old (mean age, 83 years), and so overall mortality was high (20 %). There were high frequencies of drug resistance; only 27.9 % of urinary gram-negatives and 52.6 % of blood gram-negatives were susceptible to levofloxacin. Susceptibility profiles compatible with the presence of extended-spectrum beta-lactamases were present in 64.2 % of gram-negative strains, and 10.1 % were also resistant to carbapenems. ESKAPE organisms account for a third of all bacterial infections. Local patterns of drug resistance should influence empirical antibiotic therapy for patients admitted in internal medicine wards, where mortality is high.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23184125     DOI: 10.1007/s10238-012-0219-0

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  14 in total

1.  Management of suspected bacterial urinary tract infection.

Authors:  Jason Beckford-Ball
Journal:  Nurs Times       Date:  2006 Sep 5-11

2.  ACOG Practice Bulletin No. 91: Treatment of urinary tract infections in nonpregnant women.

Authors: 
Journal:  Obstet Gynecol       Date:  2008-03       Impact factor: 7.661

3.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.

Authors:  Teresa C Horan; Mary Andrus; Margaret A Dudeck
Journal:  Am J Infect Control       Date:  2008-06       Impact factor: 2.918

4.  Strategies to prevent catheter-associated urinary tract infections in acute care hospitals.

Authors:  Evelyn Lo; Lindsay Nicolle; David Classen; Kathleen M Arias; Kelly Podgorny; Deverick J Anderson; Helen Burstin; David P Calfee; Susan E Coffin; Erik R Dubberke; Victoria Fraser; Dale N Gerding; Frances A Griffin; Peter Gross; Keith S Kaye; Michael Klompas; Jonas Marschall; Leonard A Mermel; David A Pegues; Trish M Perl; Sanjay Saint; Cassandra D Salgado; Robert A Weinstein; Robert Wise; Deborah S Yokoe
Journal:  Infect Control Hosp Epidemiol       Date:  2008-10       Impact factor: 3.254

Review 5.  General principles of antimicrobial therapy.

Authors:  R L Thompson; A J Wright
Journal:  Mayo Clin Proc       Date:  1998-10       Impact factor: 7.616

6.  The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting.

Authors:  E H Ibrahim; G Sherman; S Ward; V J Fraser; M H Kollef
Journal:  Chest       Date:  2000-07       Impact factor: 9.410

7.  Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients.

Authors:  Dirk Vogelaers; David De Bels; Frédéric Forêt; Sophie Cran; Eric Gilbert; Karen Schoonheydt; Stijn Blot
Journal:  Int J Antimicrob Agents       Date:  2010-02-01       Impact factor: 5.283

8.  Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.

Authors:  M H Kollef; G Sherman; S Ward; V J Fraser
Journal:  Chest       Date:  1999-02       Impact factor: 9.410

9.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.

Authors:  R Phillip Dellinger; Mitchell M Levy; Jean M Carlet; Julian Bion; Margaret M Parker; Roman Jaeschke; Konrad Reinhart; Derek C Angus; Christian Brun-Buisson; Richard Beale; Thierry Calandra; Jean-Francois Dhainaut; Herwig Gerlach; Maurene Harvey; John J Marini; John Marshall; Marco Ranieri; Graham Ramsay; Jonathan Sevransky; B Taylor Thompson; Sean Townsend; Jeffrey S Vender; Janice L Zimmerman; Jean-Louis Vincent
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

10.  Influx of multidrug-resistant, gram-negative bacteria in the hospital setting and the role of elderly patients with bacterial bloodstream infection.

Authors:  Aurora Pop-Vicas; E Tacconelli; Stefan Gravenstein; Bing Lu; Erika M C D'Agata
Journal:  Infect Control Hosp Epidemiol       Date:  2009-04       Impact factor: 3.254

View more
  5 in total

1.  Synthesis and evaluation of 1,2,4-triazolo[1,5-a]pyrimidines as antibacterial agents against Enterococcus faecium.

Authors:  Huan Wang; Mijoon Lee; Zhihong Peng; Blas Blázquez; Elena Lastochkin; Malika Kumarasiri; Renee Bouley; Mayland Chang; Shahriar Mobashery
Journal:  J Med Chem       Date:  2015-05-12       Impact factor: 7.446

2.  Narrow-Spectrum Antibacterial Agents.

Authors:  Roberta J Melander; Daniel V Zurawski; Christian Melander
Journal:  Medchemcomm       Date:  2017-11-06       Impact factor: 3.597

3.  Heterogeneous-Backbone Proteomimetic Analogues of Lasiocepsin, a Disulfide-Rich Antimicrobial Peptide with a Compact Tertiary Fold.

Authors:  Chino C Cabalteja; Qiao Lin; Thomas W Harmon; Shilpa R Rao; Y Peter Di; W Seth Horne
Journal:  ACS Chem Biol       Date:  2022-03-15       Impact factor: 4.634

Review 4.  Identification and management of invasive mycoses in internal medicine: a road-map for physicians.

Authors:  Marco Falcone; Ercole Concia; Ido Iori; Giuliana Lo Cascio; Antonino Mazzone; Federico Pea; Francesco Violi; Mario Venditti
Journal:  Intern Emerg Med       Date:  2014-05-29       Impact factor: 3.397

5.  The incidence and prevalence of hospital-acquired (carbapenem-resistant) Acinetobacter baumannii in Europe, Eastern Mediterranean and Africa: a systematic review and meta-analysis.

Authors:  Olaniyi Ayobami; Niklas Willrich; Thomas Harder; Iruka N Okeke; Tim Eckmanns; Robby Markwart
Journal:  Emerg Microbes Infect       Date:  2019       Impact factor: 7.163

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.